Additional European Equity News
SourceNewsquawk
SectionEuropean Equities
GSK (GSK LN) - Headline results from Phase 3 first trial; Jemperli added to chemo shows significant effect on PFS. (Newswires)
IDS (IDS LN) - EP Corporate welcomes the announcement by Chancellor of Duchy of Lancaster that he has given notice of final order in relation to IDS offer; IDS and Bidco considered approval condition and determined to be reasonable acceptable. (Newswires)
Spie (SPIE FP) - Announces the acquisition of Anyllinq in Netherlands. (Newswires)
UK Supermarkets - ONS says "For the first time in three months there was a boost for food store sales, particularly supermarkets". (Newswires)
Teamviewer (TMV GY) downgraded to Neutral from Buy at Goldman Sachs